Prescription Methods Assessment Project (PMAP)
Stopped early · Not applicable
Conditions studied: Osteoarthritis, Gastroesophageal Reflux Disease
In brief
The purpose of this study is to evaluate whether a novel prescription method (N-of-1 intervention)can be successfully integrated into primary care practices and to examine the effects of this prescription method on selected patient health outcomes (e.g.., medication compliance, medication costs, symptom management, satisfaction of physician/patient visit, etc.) in patients with a uncontrolled or new diagnosis of Osteoarthritis or Chronic Heartburn (GERD).
Key facts
- Study ID
- NCT00393653
- Run by
- American Academy of Family Physicians
- People needed
- 800
- Starts
- 2006-10-01
- Expected to finish
- 2007-05-01
- Last updated by the study team
- 2011-05-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- at least 18 years old
- capable of giving informed consent
- a new diagnosis or uncontrolled symptoms of either osteoarthritis or gastroesophageal reflux disease
- if new diagnosis or uncontrolled osteoarthritis, patient must have condition in knee or hip (need not be isolated)
You may not qualify if…
- too ill to participate
- not capable of giving informed consent
- not able to be contacted via phone for study follow-up
- unable to read English, including blindness
- if treating physician considers patient to have medical conditions that would cause the patient to be placed at risk by trial participation
Where it is running
- American Academy of Family Physicians National Research Network — Leawood, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.